The way that males and females react to environmental exposures and negative impacts on their neurological systems is often different. Although previous research has examined the cognitively impairing effects of solitary metal exposures, the relationship between metal mixtures and cognitive function, particularly when considering an individual’s sex, remains elusive. This study aimed to investigate the sex differences in the association between multiple metal combinations and cognitive function in older Americans. This research employed the 2011–2014 NHANES survey of elderly Americans. The association between five mixed metals and four cognitive tests (the animal fluency test (AFT), the digit symbol substitution test (DSST), the instant recall test (IRT), and the delayed recall test (DRT)) were investigated with generalized linear regression model (GLM), Bayesian kernel machine regression model (BKMR), weighted quantile sum regression model (WQS), and quantile g-computation regression model (Qgcomp). A total of 1833 people, including 883 males and 950 females, enrolled in this cross-sectional study. We discovered that blood lead and blood cadmium were negatively associated with cognitive performance, while blood selenium demonstrated a positive association with cognitive function in older people. The negative relationship of heavy metal combinations on cognitive function might be somewhat reduced or even reversed via selenium. The IRT, AFT, and DSST are three of the four cognitive tests where men had more dramatic positive or negative results. There was a sex-specific connection between blood metal ratios and cognitive function among older Americans, as evidenced by the more significant relationship between mixed metals and cognitive performance in men (either positively or negatively). These results emphasize the impacts of ambient heavy metal exposure on cognitive function by employing sex-specific methods.
Studies characterizing the epidemic of Mycoplasma pneumoniae ( M. pneumoniae ) in Henan Province are scarce. Our research investigated the epidemiological changes of M. pneumoniae and macrolide-resistant mutations of M. pneumonia e (MRMP) among children under 18 years from January 2017 to December 2024. The study was categorized into three stages based on the COVID-19 timeline (pre-pandemic, pandemic, and post-pandemic) to analyze the impact of nonpharmaceutical interventions (NPIs) on M. pneumoniae in Henan Province. Among 27,056 children, 28.36% tested positive for M. pneumoniae , with the lowest positivity rate in 2022 (12.56%) and the highest in 2023 (35.01%). The positivity rate was greatest in the 6–17 years (41.08%) and lowest in ≤1 year (12.38%). Epidemic seasons were predominantly in autumn (36.71%) and winter (23.12%). The MRMP rate increased from 36.68% in 2018 to 87.16% in 2023, averaging 71.00%. The positivity rate of M. pneumoniae was 26.12% during the pre-pandemic stage, significantly declined during the pandemic stage (14.97%), and rebounded to a high level in the post-pandemic stage (31.88%). The MRMP rate also increased across the three stages: 46.74%, 72.63%, and 83.31%, respectively. These results indicate a significant influence of COVID-19 NPIs on the transmission of M. pneumoniae and MRMP. IMPORTANCE: M. pneumoniae is a significant cause of community-acquired pneumonia with a high MRMP rate in China. Various NPIs in the COVID-19 pandemic have impacted the prevalence of M. pneumoniae and could have important implications for M. pneumoniae prevention and control strategies. Our study documented M. pneumoniae and MRMP detection before, during, and post the COVID-19 pandemic in Henan, China, from 2017 to 2024, aiming to investigate the impact of NPIs on M. pneumoniae transmission and continue to monitor the evolution of the epidemiological characteristics of M. pneumoniae infection after the pandemic when restrictive measures are no longer needed.
Head and neck squamous cell carcinoma (HNSCC) represents the sixth most common cancer worldwide, with pathologists routinely analyzing histological slides to diagnose cancer by evaluating cellular heterogeneity, a process that remains time-consuming and labor-intensive. Although no previous studies have systematically applied deep learning techniques to automate HNSCC TNM staging and overall stage prediction from digital histopathology slides, we developed an inception-ResNet34 convolutional neural network model (HNSC-Classifier) trained on 791 whole slide images (WSIs) from 500 HNSCC patients sourced from The Cancer Genome Atlas (TCGA) Head and Neck Squamous Cell dataset. Our pipeline was designed to distinguish cancerous from normal tissue and to predict both tumor stage and TNM classification from histological images, with the dataset split at the patient level to ensure independence between training and testing sets and performance evaluated using comprehensive metrics including receiver operating characteristic (ROC) analysis, precision, recall, F1-score, and confusion matrices. The HNSC-Classifier demonstrated exceptional performance with areas under the ROC curves (AUCs) of 0.998 for both cancer/normal classification and TNM system stage prediction at the tile level, while cross-validation showed high precision, recall, and F1 scores (>0.99) across all classification tasks. Patient-level classification achieved AUCs of 0.998 for tumor/normal discrimination and 0.992 for stage prediction, significantly outperforming existing approaches for cancer stage detection. Our deep learning approach provides pathologists with a powerful computational tool that can enhance diagnostic efficiency and accuracy in HNSCC detection and staging, with the HNSC-Classifier having potential to improve clinical workflow and patient outcomes through more timely and precise diagnoses, serving as an automated decision support system for histopathological analysis of HNSCC.
Breast cancer (BC) is the most frequently diagnosed tumor in women worldwide. Although the combination of surgery and Taxol chemotherapy can achieve a certain therapeutic effect, patients often develop drug-resistance, resulting in a poor prognosis. Therefore, it is significative to seek the molecular mechanism of chemotherapy resistance. Recent studies have found that abnormal epigenetic regulation in breast cells changes the expression of key genes, which can lead to the occurrence, development, and maintenance of cancer, even related to the development of drug-resistance. Therefore, in this study, we performed methylated DNA immunoprecipitation-sequencing (MeDIP-seq) to reveal the difference in methylation between breast cancer drug-resistant cells and sensitive cells. A total of 55076 differentially methylated genes (DMGs) were detected, including 21061 hypermethylated DMGs and 34015 hypomethylated DMGs. Moreover, Gene Ontology (GO) analysis and KEGG pathway analysis reveal the function and pathway of screening genes. These results indicate that DNA methylation may be involved in regulating the occurrence and development of breast cancer.